CD44 and neoplasm: From a CRC viewpoint, the epigenetic landscape of the xenografted tumours (e.g., originating from SK-N-SH CD44+ and CD44− cells) showed a noradrenergic phenotype (group I), suggesting that in vivo cues induced transition to adrenergic status [19].